iconstar paper   HIV Articles  
Back grey arrow rt.gif
NIH Webcast Strategies for an HIV Cure 2016 Meeting November 14 - 16, 2016
  Ruth Kirschstein Auditorium, Natcher Conference Center (Building 45)
NIH Main Campus, 9000 Rockville Pike
Bethesda, MD 20892
Thank you for your interest in the Strategies for an HIV Cure 2016 Meeting. The meeting has concluded. Footage from the meeting is available for each day here:
Day 1: https://videocast.nih.gov/summary.asp?Live=20238&bhcp=1
Day 2: https://videocast.nih.gov/summary.asp?Live=20242&bhcp=1
Day 3: https://videocast.nih.gov/summary.asp?Live=20246&bhcp=1
By Liz Kelly
By Karine Dube
The National Institute of Allergies and Infectious Diseases (NIAID) hosted its most recent HIV cure strategies meeting from November 14 – 16, 2016. The purpose of the workshop was to facilitate and foster collaboration across the new Martin Delaney Collaboratories (MDCs), the broader HIV cure research field and community stakeholders.
The Monday program opened with a keynote address by Dr. Anthony Fauci on the results of a recently completed study involving a-4-δ integrin that led to sustained virologic control of SIV in macaques, in collaboration with Emory University.
Each collaboratory provided an overview of its scientific strategy.
Each collaboratory presented its strategies towards meaningful and effective community engagement. The main topics raised by community members at the meeting included: research literacy for community and community literacy for researchers, perceptions of risks, integration of HIV cure strategies in the HIV spectrum (prevention, treatment and cure), meaningful social media strategies and evaluation of community engagement strategies.
On Tuesday November 15, 2016, Dan Kuritzkes delivered a keynote address on clinical trials in HIV cure research, including what we are learned and where we are going for each HIV cure strategy. This was followed by a review of clinical studies in the AIDS Clinical Trials Group (ACTG) – including opportunities for collaboration, as well as pediatric (IMPAACT), early antiretroviral studies and considerations for analytical treatment interruptions.
In the session of community engagement, social sciences and ethical considerations, Judy Auerbach, sociologist, provided an overview of the contributions of social sciences in HIV cure research. Regan Hoffman, advocate, provided a personal perspective on the power of HIV cure. Nir Eyal, bioethicist, discussed analytical treatment interruptions and risks to third parties (fetuses and sexual partners). Allison Mathews presented the results of a crowdsourcing content in North Carolina.
The NIH-sponsored workshop also included a session on basic HIV cure research, preclinical HIV cure research and an overview of the new amfAR HIV Cure Research Institute in San Francisco, led by Paul Volberding. The Wednesday program opened with a keynote address from Catherine Bollard on developing T cell therapies for HIV and then covered the Beyond HAART program and potentially innovative approaches to curing HIV infection.

  iconpaperstack View Older Articles   Back to Top   www.natap.org